Graphene Enclosure of Chemically Fixed Mammalian Cells for Liquid-Phase Electron Microscopy
September 21st, 2020
7.6K views
Presented here is a protocol for labeling membrane proteins in mammalian cells and coating the sample with graphene for liquid-phase scanning transmission electron microscopy. The stability of the samples against the damage caused by radiation can also studied with this protocol.
Overview
This study presents a protocol for labeling membrane proteins in mammalian cells and utilizing graphene for liquid-phase scanning transmission electron microscopy (STEM). The aim is to maintain the native environment of biological samples while minimizing electron beam-induced artifacts, thereby enabling the imaging of receptors on cancer cells.
Key Study Components
Research Area
- Cell Biology
- Microscopy
Background
- Investigation of membrane protein interactions in intact cells
- Impact on cancer treatment strategies and drug development
Methods Used
- Labeling of HER2 in mammalian cells
- Mammalian cell lines
- Scanning Transmission Electron Microscopy with graphene support
Main Results
- Successful imaging of membrane proteins without cell dehydration or sectioning
- Demonstrated retention of biological relevance in observed samples
- Establishment of a method to enhance imaging clarity and detail
Conclusions
- This study illustrates a novel approach for imaging cancer cell receptors, potentially leading to better therapeutic strategies.
- The method holds promise for advancing research in cell biology and cancer treatment.
Frequently Asked Questions
What is the main advantage of this protocol?
It allows imaging of whole cells in a native environment without dehydration or staining.
How does graphene improve the imaging process?
Graphene helps in reducing electron beam-induced artifacts while maintaining sample stability.
What type of cells were used in this study?
The study utilized mammalian cell lines, specifically demonstrating on SKBR3 cancer cells.
What protein was specifically labeled in this protocol?
HER2, a receptor known for its role in certain types of cancer.
How is the graphene prepared for use?
Graphene is coated and treated to remove polymer residues before application to microchips.
What does the study aim to achieve?
To enhance imaging techniques for better understanding and targeting of cancer therapies.
Why is maintaining a native environment important for microscopy?
It preserves the biological integrity of the samples, leading to more accurate imaging results.
Executive Industry Relevance
This protocol enables direct visualization of membrane proteins in intact cancer cells under near-native conditions, addressing a critical gap in structural oncology. By preserving hydrated state and minimizing electron beam artifacts, it supports mechanistic de-risking of receptor-targeted therapies. The approach enhances predictive confidence in early discovery by linking nanoscale protein organization to functional signaling in disease-relevant systems.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of HER2 organization in the native plasma membrane without fixation artifacts.
- Operational Value: Provides quantitative nanoscale spatial data to support target validation hypotheses.
- Predictive Value: Reduces mechanistic ambiguity in receptor clustering and signaling dynamics.
Screening & Assay Development
- Scientific Value: Generates reproducible, label-specific STEM readouts for antibody mimetic binding assays.
- Operational Value: Establishes a standardized workflow for graphene-coated sample preparation applicable to multiple targets.
- Scalability: Supports parallel processing of microchips for dose-response or mutant screening.
Translational & Preclinical Research
- Scientific Value: Maintains disease-relevant membrane ultrastructure to assess target engagement in preclinical models.
- Operational Value: Enables correlation of nanoscale imaging with functional readouts from downstream assays.
- Risk Mitigation: Supports go/no-go decisions by validating target accessibility in intact cells.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target validation to lead optimization, providing structural insights that inform antibody or small molecule design.
- Discovery Biology: Supports hypothesis testing on membrane protein nanodomain organization in HER2-positive models.
- Screening: Delivers quantitative, artifact-resistant imaging outputs for assay reproducibility and hit confirmation.
- Analytics: Enables particle pair distance measurements and dose-series analysis to quantify structural stability under perturbation.
- Translational Research: Connects molecular imaging to phenotypic outcomes by preserving native membrane context.
- Enterprise Reuse: Establishes a reusable platform for imaging diverse membrane proteins across cancer models.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation through direct visualization of receptor organization.
- Operational Value: Standardization of sample preparation via graphene encapsulation reduces variability across labs.
- Strategic Value: Informs lead selection by reducing biological uncertainty in mechanism of action.
- Portfolio Impact: Enables risk-adjusted prioritization of targets based on structural accessibility and stability.
Implementation Considerations
- Expertise in cell culture, protein labeling, and electron microscopy sample preparation.
- Access to STEM instrumentation with graphene transfer capabilities and environmental control.
- Standardization of graphene coating protocols across teams for reproducible results.
- Adaptation considerations for different cell lines and membrane protein targets.
- Practical limitations include throughput constraints and specialized equipment requirements.
Biopharma FAQs
Why does electron beam damage matter for target validation in membrane protein studies?
Electron beam-induced artifacts can distort protein localization and clustering, leading to false conclusions about target accessibility. Graphene coating mitigates this by maintaining sample hydration and reducing radiolysis, ensuring observed structures reflect native biology. This supports reliable target validation in oncology discovery programs.
How does isolating the quantum dot labeling signal enable accurate HER2 quantification?
The quantum dot nanoparticles serve as specific, bright labels for HER2, allowing precise detection against cellular background in STEM images. By isolating this signal, researchers can measure receptor density and distribution without interference from nonspecific binding. This enables quantitative assessment of labeling efficiency and target engagement.
What do quantitative distance measurements between labeled particles reveal about receptor behavior?
Changes in inter-particle distance under electron beam exposure indicate structural stability of the labeled protein complexes. Smaller distance shifts in graphene-coated samples suggest better preservation of native receptor organization. These measurements provide a quantitative metric for assessing sample integrity during imaging.
Why are replication requirements critical for comparing coated and non-coated samples in beam damage studies?
Replication ensures that observed differences in artifact formation are due to graphene protection rather than sample variability. Consistent results across multiple microchips confirm the reliability of the coating method. This supports cross-functional trust in the data for go/no-go decisions in target validation workflows.
What statistical analysis is needed to interpret dose-series experiments in graphene-coated STEM imaging?
Dose-series experiments require statistical comparison of artifact frequency or distance changes between coated and non-coated groups across increasing electron doses. Analysis such as t-tests or ANOVA determines whether graphene coating significantly reduces beam-induced damage. This establishes a quantitative threshold for implementing the method in routine screening or validation pipelines.
